|
Dr. Russell manages all clinical, medical, regulatory, drug safety and biometrics matters worldwide. She has broad expertise leading clinical research initiatives as a physician and senior executive with pharmaceutical research companies in the United States and United Kingdom, with particular strength in oncology.
Dr. Russell came to Cephalon in January 2000 from US Bioscience Inc./Medimmune Oncology, where she was Vice President Clinical Research, responsible for directing and implementing the clinical programs in oncology and HIV research. Prior to joining US Bioscience, Dr. Russell was Director of Clinical Research at USB Pharma Ltd, the European subsidiary of US Bioscience. Before her work at USB Pharma, Dr. Russell was a Clinical Research Physician at Eli Lilly UK, responsible for the oncology clinical trial program in the UK. Dr. Russell was Medical Director at Amgen UK.
Before joining the pharmaceutical industry, Dr. Russell was trained in Hematology/Oncology at Royal Infirmary of Edinburgh, and Royal Hospital for Sick Children Edinburgh UK and was a Research Fellow at University of Edinburgh Faculty of Medicine. She received a MB.Ch.B. degree from University of Edinburgh, Scotland, Faculty of Medicine and is a member of the Royal College of Physicians, UK. | 